Skip to main content
Clinical Trials/NCT07033611
NCT07033611CompletedNot Applicable

Effects of Creatine Supplementation in Sarcopenic and Non-sarcopenic Patients on Chronic Hemodialysis

Carla Basualto Alarcón1 site in 1 country18 target enrollmentStarted: January 1, 2024Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
18
Locations
1
Primary Endpoint
Compare Short Physical Performance Battery (SPPB) before and after 8 weeks of creatine use

Study Overview

Brief Summary

Adult patients undergoing chronic dialysis therapy for at least three months were selected. A physical function assessment was conducted, including the Short Physical Performance Battery (SPPB) and a handgrip strength test. Additionally, a bioelectrical impedance analysis was performed. Subsequently, 5 grams of creatine were administered daily for a period of eight weeks, after which the same assessments were repeated. The results were then analyzed to identify any differences in the tests, aiming to detect potential changes following creatine supplementation.

Detailed Description

Adult patients undergoing chronic dialysis therapy for at least three months were selected, primarily based on their good adherence to pharmacological and dialysis treatment regimens. A physical function assessment was conducted, including the Short Physical Performance Battery (SPPB) and a handgrip strength test. Additionally, a bioelectrical impedance analysis was performed.

All participants were informed that creatine would be administered and provided written informed consent. The study protocol was approved by the local ethics committee.

Creatine supplementation consisted of 5 grams per day for eight weeks. On dialysis days, the dose was administered immediately after the dialysis session. On non-dialysis days, patients were responsible for self-administering the creatine at home. The creatine was diluted in 100 mL of water before ingestion.

All assessments were conducted the day following the second dialysis session of the week-on Thursday or Friday, depending on the patient's schedule. There was no control group so pre-creatine measurements were considered as the basal (control) state. Measurements were taken before and after the creatine supplementation period in the same patients. The data were analyzed to evaluate changes in the outcomes following creatine use.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Eligible to provide informed consent
  • •At least three months on chronic dialysis therapy
  • •No physical impairments that would prevent completion of the SPPB or bioelectrical impedance analysis

Exclusion Criteria

  • •Pregnancy
  • •Use of any nutritional supplement

Arms & Interventions

Pre creatine and post

Experimental

patients before and after creatine suplemmentation

Intervention: Creatine (Dietary Supplement)

Outcomes

Primary Outcomes

Compare Short Physical Performance Battery (SPPB) before and after 8 weeks of creatine use

Time Frame: eigth weeks

To compare the physical functionality status of selected patients, as assessed by the Short Physical Performance Battery (SPPB), before and after eight weeks of creatine supplementation. Scale range between 0-12 points. Higher points mean a better outcome (higher physical functionality).

Secondary Outcomes

  • Compare hand grip strength as assessed by a hand dynamometer, before and after eight weeks of creatine supplementation(eigth weeks)
  • Compare body composition: skeletal muscle mass, estimated by bioimpedance analysis before and after eight weeks of creatine supplementation(eigth weeks)
  • Compare body composition: fat free mass, estimated by bioimpedance analysis before and after eight weeks of creatine supplementation(eigth weeks)
  • Compare body composition: total body water (Lt), estimated by bioimpedance analysis before and after eight weeks of creatine supplementation(eigth weeks)
  • Compare body composition: extracellular water (Lt), estimated by bioimpedance analysis before and after eight weeks of creatine supplementation(eigth weeks)
  • Compare body composition: intracellular water (Lt), estimated by bioimpedance analysis before and after eight weeks of creatine supplementation(eigth weeks)
  • Compare body composition: phase angle (degrees), estimated by bioimpedance analysis before and after eight weeks of creatine supplementation(eigth weeks)

Investigators

Sponsor
Carla Basualto Alarcón
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Carla Basualto Alarcón

Associate Professor, U Aysen. MD., MSc., PhD.

Universidad de Aysén

Study Sites (1)

Loading locations...

Similar Trials